A significant public health initiative will offer a Meningitis B vaccine to approximately one million young people in England, Wales, and Scotland. This one-off program aims to provide protection against the potentially life-threatening bacterial infection, which has seen notable outbreaks.

The vaccine rollout comes in response to growing concerns over the UK's largest and most rapidly expanding Meningitis B outbreak recorded this year in Kent. Additional clusters have also been identified in Weymouth and Reading, prompting health officials to act.

The two-dose vaccine will be made available to students in their final year of secondary school and individuals aged 18 to 25 who are beginning university or residential further education this autumn. Health authorities stated the program is designed to safeguard those identified as being at the highest immediate risk.

Meningococcal disease, caused by meningococcal bacteria, can swiftly progress to severe illness. The bacteria spread through close contact, including sharing vapes, drinks, or living in close proximity.

UK health officials have highlighted that individuals aged 18 or those entering university for the first time face a heightened risk due to increased social mixing and shared living environments. This differs from the routine MenACWY vaccine offered to 14-year-olds, which covers different strains of meningitis.

The urgency of the situation was underscored by the tragic death of 18-year-old Aaron Mills in January 2026. Mills, who had recently begun his university studies, developed mild flu-like symptoms that rapidly escalated. His mother described a harrowing experience where he became unresponsive and fitting within minutes of returning to bed with a headache.

Aaron's parents expressed confusion, as they believed he had already been vaccinated, only to later learn about the existence of different meningitis strains. The family has spoken about the devastating and unbearable pain caused by his loss, emphasizing the horrific impact on family and friends.

While specific implementation details may vary slightly between the nations, the MenB vaccination program will broadly target most pupils completing Year 13 or S6 in the summer of 2026, regardless of their future educational plans. This proactive measure seeks to mitigate the impact of the current Meningitis B outbreak.